Role of Presenilin1 and Beta-Catenin Interaction In Vivo

About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000019
Summary
The PS1 gene is expressed throughout the bodies of all mammals. The complete loss of the PS1 gene in laboratory mice causes a lethal condition in mouse embryos. However, specialized mouse strains that have been engineered to express the human PS1 in the central nervous system, but not elsewhere, can survive. Dr. Zheng has found that these mice develop epidermal hyperplasia and neoplasm, or skin cancer, and that the skin cancer phenotype is similar to that found for transgenic mice that exhibit overactivity in the molecule Beta-Catenin. Dr. Zheng has proposed that this molecule interacts with PS1 and plays a role in cell signaling. In this study, she is attempting to determine the molecular mechanisms of PS1 in the growth of tumors. Then the discovery will be utilized to generate specific mutations in PS1 to further examine its interaction with Beta-Catenin. Because this technique allows the survival of mice whose expression of PS1 has been inhibited, it is hoped that a better understanding of the role of PS-1 in adult tissues will be attained.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015

Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD